Cardiovascular disease: risk assessment and reduction, including lipid modification

Consultation comments and responses (PDF 2.44 MB)

Supporting documentation Acknowledgements (PDF 195 KB)

Committee member list (PDF 142 KB)

Draft guidance consultation

Draft guideline (PDF 306 KB)

Evidence review D - escalation of lipid modification therapy for secondary prevention (PDF 7.13 MB)

Evidence review Codes list for lipids (Excel 834 KB)

Evidence review Network meta-analysis for change in LDL-C and non-HDL-C (PDF 1.06 MB)

Supporting documentation Methods chapter (PDF 503 KB)

Economic report (PDF 3.72 MB)

Comments form (MSWord 48 KB)

Statement Information Event slideset (PDF 339 KB)

Statement Information Event Non-industry attendees  (PDF 98 KB)

Economic plan (PDF 103 KB)

Committee meeting

Minutes 1 (PDF 209 KB)

Minutes 2 (PDF 217 KB)

Minutes 3 (PDF 238 KB)

Minutes 4 (PDF 231 KB)

Minutes 5 (PDF 229 KB)

Workshop notes - attendee list (PDF 125 KB)

Workshop notes - discussions (PDF 376 KB)